8X3-14041-60549
3 vaccinations
4 coded responses
26 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-06-22
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-21
Dose 1 — Pfizer-BioNTech
-
2021-06-22
Registered in v-safe
-
2021-06-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
-
2021-06-27
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: GoodFree text: Slight congestion, heavier breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-28
- 2021-07-05
- 2021-07-14
-
2021-07-15
Dose 2 — Pfizer-BioNTech
- 2021-07-19
-
2021-07-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Headache, Abdominal painAdult check-in
- 2021-07-21
- 2021-07-24
- 2021-07-29
-
2021-08-05
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Headaches every dayMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-12
- 2021-08-19
- 2021-08-26
- 2021-10-16
-
2022-01-06
Dose 3 — Moderna
- 2022-01-13
-
2022-01-13
Health check-in — day 7, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-01-20
-
2022-01-27
Survey response — day 21, dose 3MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, congestion, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-02-03
- 2022-02-10
-
2022-02-17
Survey response — day 42, dose 3MedDRA: Disturbance in attention, Fatigue — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, difficulty focusingMedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-21 | Pfizer-BioNTech | No |
| 2 | 2021-07-15 | Pfizer-BioNTech | No |
| 3 | 2022-01-06 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Slight congestion, heavier breathing
Release 9 — day 21, dose 2
Symptoms: Headaches every day
Release 11 — day 21, dose 3
Symptoms: Sore throat, congestion, headache
Release 11 — day 42, dose 3
Symptoms: Fatigue, difficulty focusing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Disturbance in attention | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release